Speech-Language Pathologists in Beloit, WI Accepting Medicare
8 Speech-Language Pathologists found. Showing 1 - 8
 Jessica M. Frantz, CCC/SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1969 W Hart Rd, Beloit Health System Inc/ Beloit Memorial Hospital, Beloit, WI 53511 Phone: 608-364-5695 Fax: 608-363-5790 |
Nicole Rich Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1905 W Hart Rd, Beloit, WI 53511 Phone: 608-365-7500 |
Ms. Allison Ashley Wester, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2121 Pioneer Dr, Beloit, WI 53511 Phone: 608-365-9526 |
Lauren E Turner, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1905 W Hart Rd, Beloit, WI 53511 Phone: 608-467-6780 |
Ms. Louann Zink, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1905 W Hart Rd, Beloit, WI 53511 Phone: 608-365-2554 |
Andrea Lynn Tregoning, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1969 W Hart Rd, 1969 W. Hart Road, Beloit, WI 53511 Phone: 608-364-5203 Fax: 608-363-5790 |
Ms. Michelle Suzanne Dishinger, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1905 W Hart Rd, Beloit, WI 53511 Phone: 608-365-7500 |
Allison G. Petska, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1969 W. Hart Road, Beloit Health System Inc, Beloit, WI 53511 Phone: 608-364-5173 Fax: 608-363-5790 |
News Archive
Dispute between hospital, insurer highlight health reform challenge
In Texas, the region's largest insurer and one of the state's largest hospitals are at odds over patient costs while Wisconsin's hospitals give a boost to economy by adding jobs.
Positive impact of parents as teachers
Today, new research was unveiled on the outcomes of Parents as Teachers participation on children's school readiness and how these effects are sustained through third grade.
Eleven Biotherapeutics reports positive results from EBI-005 Phase 1b/2a study in patients with DED
Eleven Biotherapeutics, a biopharmaceutical company designing and engineering novel and differentiated protein-based biotherapeutics for ocular diseases, announced today positive topline clinical results from a 6-week randomized, double-masked, placebo-controlled Phase 1b/2a study of EBI-005 in patients with dry eye disease.
Fifteen-year hunt uncovers gene behind pseudothalidomide syndrome
A team of scientists from Colombia, the United States and elsewhere has successfully completed a 15-year-plus search for the genetic problems behind the very rare Roberts syndrome, whose physical manifestations often include cleft lip and palate and shortened limbs that resemble those of babies whose mothers took thalidomide during pregnancy.
› Verified 1 days ago
Physical Therapists
Occupational Therapists
Chiropractors
Speech-Language Pathologists
Optometrists
Audiologists
Podiatrists